Accrol Group Holdings PLC Regulatory Investigation Update (1694U)
March 27 2019 - 6:20AM
UK Regulatory
TIDMACRL
RNS Number : 1694U
Accrol Group Holdings PLC
27 March 2019
27 March 2019
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014. Upon the publication of
this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
Accrol Group Holdings plc
("Accrol" or the "Company")
Regulatory Investigation Update
Further to the announcement dated 21 January 2019, entitled
"Regulatory Investigation" (RNS number 6698N), the FCA has notified
Accrol that the period it is investigating has been revised from 1
April 2017 to 20 November 2017 to 10 June 2016 to 30 September
2018, to cover the period from the date Accrol's share capital was
admitted to trading on AIM to the date the Company's audited
accounts for the year ended 30 April 2018 ("2018 Accounts") were
made public. The 2018 Accounts identified misstatements in the
previously published accounts for the period 1 May 2016 to 30 April
2017.
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Tel: +44 (0) 1254 278 844
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser
& Broker)
Dan Bate / Andrew Jones Tel: +44 (0) 161 831 1512
Dominic King / John Goold Tel: +44 (0) 203 829 5000
Belvedere Communications Limited
Cat Valentine (cvalentine@belvederepr.com) Tel: +44 (0) 7715 769 078
Keeley Clarke (kclarke@belvederepr.com) Tel: +44 (0) 7967 816 525
Llew Angus (langus@belvederpr.com) Tel: +44 (0)7407 023 147
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading
tissue converter and supplier of toilet rolls, kitchen rolls and
facial tissues, as well as other tissue products, to major
discounters and grocery retailers throughout the UK. Accrol
operates from three sites:
-- A manufacturing, storage and distribution
facility in Blackburn;
-- A facial tissue plant, also in Blackburn;
and
-- A manufacturing, storage and distribution
facility in Leyland.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCEAEDXAFXNEFF
(END) Dow Jones Newswires
March 27, 2019 06:20 ET (10:20 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024